A trial study of leukocyte labeling with stabilized Tc-99m D,L-HMPAO by methylene blue and sodium phosphate buffer

Applied Radiation and Isotopes

Volumn 50, Issue 3, 1999, Pages 513-519

  Kao, C H ^a   Huang, W T ^b   Wey, S P ^d   Changlai, S P ^c   Liao, K K ^c   Tsai, C S ^d  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

DYES; RADIOACTIVE TRACERS; SODIUM COMPOUNDS; TECHNETIUM;

RADIOCHEMISTRY; RADIOLABELING; SODIUM PHOSPHATE;

CYTOLOGY;

BUFFER; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; METHYLENE BLUE; SODIUM DIHYDROGEN PHOSPHATE;

ARTICLE; CELL LABELING; CELL VIABILITY; CONTROLLED STUDY; DRUG STABILITY; HUMAN; HUMAN CELL; LEUKOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; THERMOSTABILITY;

APPENDICITIS; BUFFERS; CEREBROVASCULAR CIRCULATION; DRUG STABILITY; HUMANS; LEUKOCYTES; MALE; METHYLENE BLUE; MIDDLE AGED; PHOSPHATES; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME;

EID: 0033103872     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8043(98)00085-2     Document Type: Article

References (19)

1. Becker W., Schomann E., Fischbach W., Borner W., Gruner K.R. Comparison of Tc-99m-HMPAO and In-111-oxime labeled granulocytes in man: first clinical results. Nucl. Med. Comm. 9:1988;435-447.
2. Ceretec package insert, 1990. Author, please provide reference.
3. Ceretec package insert, 1995. Amersham.
4. Colas-Linhart, N., 1984. Technique of cell handling and viability testing. In: Fueger, G.F. (Ed.), Blood Cells in Nuclear Medicine, Part II. Martinus Nijhoff Publisher, Boston, pp. 117-137.
5. Gartshore G., Bannan P., Patterson J., Higley B., McCulloch J. Evaluation of technetium-99m exametazime stabilised with cobalt chloride as a blood flow tracer in focal cerebral ischaemia. Eur. J. Nucl. Med. 21:1994;913-923.
6. Hung J.C., Volkert W.A., Holmes R.A. Stabilization of Tc-99m-D,L-HMPAO using gentisic acid. Int. J. Nucl. Med. Biol. 16:1989;675-680.
7. Hung J.C., Chowdhury S., Mullan B.P. The use of stabilized technetium-99m-exametazime for radiolabeling leukocytes [Abstract]. J. Nucl. Med. 5 (Suppl.):1996;84P.
8. Hung J.C., Chowdhury S., Mullan B.P. The use of stabilized Tc-99m exametazime to radiolabel leukocytes with three leukocyte separation methods [Abstract]. Eur. J. Nucl. Med. 9:1996;1181.
9. Kao C.H., Wang Y.L., Wang S.J. Elution analysis and normal biodistribution of technetium-99m HMPAO-labeled white blood cells. J. Nucl. Med. Technol. 20:1992;224-227.
10. Kao C.H., Huang W.T., Wang Y.L., Lin K.S., Lo J.M., Wang S.J. A comparative study of Tc-99m HMPAO and Tc-99m ECD as a leukocyte labeling agent. Nucl. Med. Commun. 15:1994;294-297.
11. Lantto E.H., Lantto T.J., Vorne M. Fast diagnosis of abdominal infections and inflammations with technetium-99m-HMPAO labeled leukocytes. J. Nucl. Med. 32:1991;2029-2034.
12. Mang'era K.O., Vanbilloen H.P., Schiepers C.W., Verbruggen A.M. Stabilization of high-activity 99mTc-D,L-HMPAO preparations with cobalt chloride and their biological behaviour. Eur. J. Nucl. Med. 22:1995;1163-1172.
13. Mountford P.J., Kettle A.G., O'Koherty M.J., Coakley A.J. Comparison of Technetium-99m-HM-PAO leukocytes with Indium-111-oxine leukocytes for localizing intraabdominal sepsis. J. Nucl. Med. 31:1990;311-315.
14. Neirinckx R., Canning L.R., Piper I.M., Nowotnik D.P., Pickett R.D., Holmes R.A., Volkert W.A., Forster A.M., Weisner P.S., Marriott J.A. Technetium-99m D,L-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J. Nucl. Med. 28:1987;191-202.
15. Peters A.M., Roddie M.E., Danpure H.J., Osman S., Zacharopoulos G.P., George P., Stuttle A.W., Lavender J.P. Tc-99m-HMPAO labeled leukocytes: comparison with In-111-tropolone labeled granulocytes. Nucl. Med. Comm. 9:1988;449-463.
16. Society of Nuclear Medicine: Procedure guideline for Tc-99m exametazime (HMPAO) labeled leukocyte scintigraphy for suspected infection/inflammation. June 27, 1996.
17. Tsai C.S., Kao C.H., Yeh S.J., Wang S.J. A comparative study of Tc-99m-D,L-HMPAO and Tc-99m-D,L-CBPAO as a leukocyte labeling agent. Nucl. Med. Commun. 17:1996;76-79.
18. Tubergen K., Corlija M., Volkert W.A., Holmes R.A. Sensitivity of technetium-99m-D,L-HMPAO to radiolysis in aqueous solutions. J. Nucl. Med. 32:1991;111-115.
19. Weisner P.S., Bower G.R., Dollimore L.A., Forster A.M., Higley B., Storey A.E. A method for stabilising technetium-99m exametazime prepared from a commercial kit. Eur. J. Nucl. Med. 20:1993;661-666.